Division of Rheumatology and Immunology

Tracy Frech, MD, MSCI
July 8, 2024

Tracy Frech named director of the Division of Rheumatology and Immunology

Tracy Frech, MD, MSCI, has been named to direct the division of Rheumatology and Immunology in the Department of Medicine at Vanderbilt University Medical Center, and will assume the new role Sept. 1.

By Doug Campbell
May 18, 2023

Billing codes aid lupus diagnosis

Vanderbilt researchers used billing codes in electronic health records to develop a “phenotype risk score” that identified established and undiagnosed people with lupus.

By Bill Snyder
Jeffrey Rathmell, PhD, left, and Kelsey Voss, PhD, led a multidisciplinary team that identified iron metabolism in T cells as a potential target for treating lupus.
January 13, 2023

Study identifies potential new approach for treating lupus

A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus.

By Leigh MacMillan
November 21, 2022

Vanderbilt mourns loss of former Rheumatology director Thomas

James Ward “Tom” Thomas II, MD, former director of Vanderbilt’s Division of Rheumatology and Immunology, died Nov. 16 following a battle with cancer. He was 74.

By Doug Campbell
(iStock)
October 6, 2022

VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.

By Bill Snyder
August 25, 2022

Rheumatoid arthritis and heart disease: a common path

An increase in certain antibodies in patients with rheumatoid arthritis can serve as a predictive biomarker for cardiovascular disease, Vanderbilt researchers have discovered.

By Bill Snyder
August 4, 2022

VUMC lauded for scleroderma treatment, research

Vanderbilt University Medical Center was recently listed as a Designated Scleroderma Research and Treatment Center by the National Scleroderma Foundation.
By Doug Campbell
July 20, 2022

Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
By Leigh MacMillan
June 29, 2022

Study shows genotype leads to discontinued, decreased medication

By Jill Clendening
March 28, 2022

Rheumatoid arthritis: special deliveries

Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.
By Bill Snyder
September 16, 2021

Chung receives early investigator award from ASCPT

Vanderbilt's Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
By Bill Snyder
August 24, 2021

Autoimmunity advance

Vanderbilt researchers have developed a high-throughput screening method to identify and characterize antigen-specific B cells — potential biomarkers for autoimmune disease and targets for new treatments.
By Leigh MacMillan
April 20, 2021

New Clinician Spotlight: Jason Springer

Jason Springer, MD, MS, has joined Vanderbilt University Medical Center as associate professor of Medicine in the Division of Rheumatology and Immunology in the Department of Medicine. Springer is co-director of the Vanderbilt Vasculitis Center, where he will oversee vasculitis clinical trials.
By VUMC News and Communications
1 2 3